![Christina TRIPSAS | Researcher | Doctor of Medicine | Dana-Farber Cancer Institute, Boston | DFCI | Bing Center for Waldenstrom's Macroglobulinemia Christina TRIPSAS | Researcher | Doctor of Medicine | Dana-Farber Cancer Institute, Boston | DFCI | Bing Center for Waldenstrom's Macroglobulinemia](https://www.researchgate.net/profile/Christina-Tripsas/publication/44679636/figure/fig5/AS:668402444161029@1536370969325/Expression-of-UGT2B17-mRNA-in-EC-and-adjacent-normal-uterus-tissues-Expression-levels-of_Q320.jpg)
Christina TRIPSAS | Researcher | Doctor of Medicine | Dana-Farber Cancer Institute, Boston | DFCI | Bing Center for Waldenstrom's Macroglobulinemia
![VS38 staining contributes to a novel gating strategy in flow cytometry for small B cell lymphoma, especially in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia - Mizuta - 2022 - Cytometry Part B: Clinical Cytometry - Wiley Online Library VS38 staining contributes to a novel gating strategy in flow cytometry for small B cell lymphoma, especially in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia - Mizuta - 2022 - Cytometry Part B: Clinical Cytometry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c4f7884a-de8a-48d6-a6ab-963b4736fdb1/cytob22000-fig-0001-m.jpg)
VS38 staining contributes to a novel gating strategy in flow cytometry for small B cell lymphoma, especially in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia - Mizuta - 2022 - Cytometry Part B: Clinical Cytometry - Wiley Online Library
![Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia | Clinical Cancer Research Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia | Clinical Cancer Research](https://clincancerres.aacrjournals.org/content/clincanres/17/7/1753/F1.large.jpg)
Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia | Clinical Cancer Research
![Christina TRIPSAS | Researcher | Doctor of Medicine | Dana-Farber Cancer Institute, Boston | DFCI | Bing Center for Waldenstrom's Macroglobulinemia Christina TRIPSAS | Researcher | Doctor of Medicine | Dana-Farber Cancer Institute, Boston | DFCI | Bing Center for Waldenstrom's Macroglobulinemia](https://www.researchgate.net/profile/Christina-Tripsas/publication/44679636/figure/fig6/AS:668402444169227@1536370969348/The-mRNA-expression-level-of-Mcl-1-in-EC-and-matched-adjacent-normal-uterus-tissues_Q320.jpg)
Christina TRIPSAS | Researcher | Doctor of Medicine | Dana-Farber Cancer Institute, Boston | DFCI | Bing Center for Waldenstrom's Macroglobulinemia
![Vaccines | Free Full-Text | New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM | HTML Vaccines | Free Full-Text | New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM | HTML](https://www.mdpi.com/vaccines/vaccines-08-00164/article_deploy/html/images/vaccines-08-00164-g001a-550.jpg)
Vaccines | Free Full-Text | New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM | HTML
![Cancers | Free Full-Text | Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell Lymphomas | HTML Cancers | Free Full-Text | Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell Lymphomas | HTML](https://www.mdpi.com/cancers/cancers-12-01328/article_deploy/html/images/cancers-12-01328-g001.png)
Cancers | Free Full-Text | Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell Lymphomas | HTML
![Vaccines | Free Full-Text | New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM | HTML Vaccines | Free Full-Text | New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM | HTML](https://www.mdpi.com/vaccines/vaccines-08-00164/article_deploy/html/images/vaccines-08-00164-g003.png)
Vaccines | Free Full-Text | New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM | HTML
![JCM | Free Full-Text | Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies | HTML JCM | Free Full-Text | Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies | HTML](https://www.mdpi.com/jcm/jcm-07-00062/article_deploy/html/images/jcm-07-00062-g0A1.png)
JCM | Free Full-Text | Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies | HTML
Full article: The Central Role for Microenvironment in B-Cell Malignancies: Recent Insights into Synergistic Effects of its Therapeutic Targeting and Anti-CD20 Antibodies
![IJMS | Free Full-Text | The CXCR4–CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro | HTML IJMS | Free Full-Text | The CXCR4–CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro | HTML](https://www.mdpi.com/ijms/ijms-20-04740/article_deploy/html/images/ijms-20-04740-ag.png)
IJMS | Free Full-Text | The CXCR4–CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro | HTML
![Christina TRIPSAS | Researcher | Doctor of Medicine | Dana-Farber Cancer Institute, Boston | DFCI | Bing Center for Waldenstrom's Macroglobulinemia Christina TRIPSAS | Researcher | Doctor of Medicine | Dana-Farber Cancer Institute, Boston | DFCI | Bing Center for Waldenstrom's Macroglobulinemia](https://www.researchgate.net/profile/Christina-Tripsas/publication/44679636/figure/fig1/AS:276810504916992@1443008175138/Expression-of-UGT2B17-mRNA-in-EC-cells-A-and-the-effect-of-si-UGT2B17-on-Ishikawa_Q320.jpg)